OCP (ppb) | 1st tertile | 2nd tertile | 3rd tertile | |
---|---|---|---|---|
OR (95% CI) | OR (95% CI) | |||
α-HCH | Model 1 | Referent | 0.82 (0.63–1.25) | 0.99 (0.83–1.55) |
Model 2 | 0.68 (0.54–1.49) | 1.72 (0.83–4.58) | ||
Model 3 | 0.65 (0.43–1.48) | 1.95 (0.93–5.18) | ||
β-HCH | Model 1 | Referent | 0.66 (0.48–1.12) | 1.72 (0.48–2.04) |
Model 2 | 0.79 (0.62–1.67) | 1.66 (0.72–2.53) | ||
Model 3 | 0.57 (0.45–1.69) | 1.29 (0.50–2.16) | ||
γ-HCH | Model 1 | Referent | 0.52 (0.37–1.14) | 1.82 (0.83–3.58) |
Model 2 | 0.78 (0.62–4.04) | 2.05 (1.84–4.04)* | ||
Model 3 | 0.63 (0.37–1.0) | 0.93 (0.77–3.30) | ||
Aldrin | Model 1 | Referent | 0.28 (0.16–1.24) | 1.61 (0.77–3.32) |
Model 2 | 0.64 (0.45–1.64) | 1.05 (0.95–3.11) | ||
Model 3 | 0.85 (0.89–1.27) | 1.15 (0.89–3.87) | ||
Dieldrin | Model 1 | Referent | 0.48 (0.37–1.56) | 0.96 (0.57–1.56) |
Model 2 | 0.84 (0.52–1.96) | 0.52 (0.32–1.87) | ||
Model 3 | 0.94 (0.75–1.68) | 0.89 (0.58–2.53) | ||
α-endosulfan | Model 1 | Referent | 0.39 (0.17–1.66) | 1.05 (0.92–3.53) |
Model 2 | 0.92 (0.64–1.62) | 0.87 (0.38–2.49) | ||
Model 3 | 0.88 (0.52–2.18) | 1.30 (0.63–2.67) | ||
β-endosulfan | Model 1 | Referent | 0.58 (0.49–1.85) | 1.41 (0.68–2.87) |
Model 2 | 0.48 (0.22–1.64) | 1.92 (1.15–3.00)* | ||
Model 3 | 0.92 (0.85–2.67) | 2.16 (1.68–4.86)* | ||
p, p′-DDT | Model 1 | Referent | 0.64 (0.32–1.94) | 0.95 (0.32–2.93) |
Model 2 | 0.64 (0.28–1.60) | 1.71 (0.68–3.90) | ||
Model 3 | 1.56 (0.96–2.68) | 1.02 (0.59–2.50) | ||
p, p′-DDE | Model 1 | Referent | 0.49 (0.22–1.46) | 1.63 (1.10–2.93)* |
Model 2 | 0.59 (0.52–1.64) | 2.13 (1.02–4.47)* | ||
Model 3 | 1.87 (0.99–2.49) | 3.20 (1.48–6.94)* |